Evidence map›Paper›PMID 22298120›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2012

Corticotropin-releasing factor modulation of forebrain GABAergic transmission has a pivotal role in the expression of anabolic steroid-induced anxiety in the female mouse.

Joseph G Oberlander, Leslie P Henderson

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Maternal testosterone exposure increases anxiety-like behavior and impacts the limbic system in the offspring.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Joseph G OberlanderDepartment of Physiology & Neurobiology, Dartmouth Medical School, Hanover, NH, USA.
Leslie P Henderson
Dartmouth College · US

Funding

PROJECT 3 - Steroid-Metabolic Interactions In the Control of GnRH NeuronsU54HD028934 · NICHD · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI MARSHALL, JOHN C · 1998 to 2013
$16.5M
Steroid Regulation of Ion ChannelsR01DA014137 · NIDA · DARTMOUTH COLLEGE · PI HENDERSON, LESLIE P · 2001 to 2011
$3.0M
THE ROLE OF HORMONES IN HEALTH AND DISEASET32DK007508 · NIDDK · DARTMOUTH COLLEGE · PI NORTH, WILLIAM G · 1986 to 2011
$2.5M
Interactions of Anabolic Steroids and Stress Hormones in the ForebrainR03DA022716 · NIDA · DARTMOUTH COLLEGE · PI HENDERSON, LESLIE P · 2007 to 2008
$151k
NICHD NIH HHS U54 HD028934NICHD NIH HHS U54 HD28934NIDA NIH HHS DA014137NIDA NIH HHS DA022716NIDA NIH HHS R01 DA014137NIDA NIH HHS R03 DA022716NIDDK NIH HHS DK07508NIDDK NIH HHS T32 DK007508
6 · The paper itself

Abstract

Increased anxiety is commonly observed in individuals who illicitly administer anabolic androgenic steroids (AAS). Behavioral effects of steroid abuse have become an increasing concern in adults and adolescents of both sexes. The dorsolateral bed nucleus of the stria terminalis (dlBnST) has a critical role in the expression of diffuse anxiety and is a key site of action for the anxiogenic neuromodulator, corticotropin releasing factor (CRF). Here we demonstrate that chronic, but not acute, exposure of female mice during adolescence to AAS augments anxiety-like behaviors; effects that were blocked by central infusion of the CRF receptor type 1 antagonist, antalarmin. AAS treatment selectively increased action potential (AP) firing in neurons of the central amygdala (CeA) that project to the dlBnST, increased the frequency of GABA(A) receptor-mediated spontaneous inhibitory postsynaptic currents (sIPSCs) in dlBnST target neurons, and decreased both c-FOS immunoreactivity (IR) and AP frequency in these postsynaptic cells. Acute application of antalarmin abrogated the enhancement of GABAergic inhibition induced by chronic AAS exposure whereas application of CRF to brain slices of naïve mice mimicked the actions of this treatment. These results, in concert with previous data demonstrating that chronic AAS treatment results in enhanced levels of CRF mRNA in the CeA and increased CRF-IR in the dlBnST neuropil, are consistent with a mechanism in which the enhanced anxiety elicited by chronic AAS exposure involves augmented inhibitory activity of CeA afferents to the dlBnST and CRF-dependent enhancement of GABAergic inhibition in this brain region.

Indexed as

Acoustic StimulationAction PotentialsAmygdalaAnalysis of VarianceAndrogensAnimalsAnxietyCorticotropin-Releasing HormoneDisease Models, AnimalDose-Response Relationship, DrugFemaleGABAergic NeuronsInhibitory Postsynaptic PotentialsInjections, IntraventricularIn Vitro TechniquesMiceAndrogensantalarminCorticotropin-Releasing HormoneProto-Oncogene Proteins c-fosPyrimidinesPyrrolesRNA, Messenger

Identifiers

PMID22298120
PMCPMC3327853
OpenAlexW2075063824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.